Guenthner, Scott
McFalda, Wendy
Kwong, Pearl
Eads, Kimberly
McCafferty, Morgan
Rieger, Jayson
Glover, David K.
Willson, Cynthia
Burnett, Patrick
Olivadoti, Melissa
Clinical trials referenced in this document:
Documents that mention this clinical trial
COVE-1: A Phase 2, Open-Label Study to Evaluate Efficacy and Safety and the Optimal Regimen of VP-102, a Proprietary Drug–Device Product Containing Topical Cantharidin (0.7% w/v) Under Occlusion for the Treatment of Common Warts
https://doi.org/10.1007/s13555-021-00576-y
Funding for this research was provided by:
Verrica Pharmaceuticals
Article History
Received: 21 April 2021
Accepted: 1 July 2021
First Online: 21 July 2021